
News|Articles|January 26, 2026
AAP publishes 2026 childhood and adolescent immunization schedule
Author(s)Morgan Ebert, Executive Editor
Fact checked by: Celeste Krewson, Assistant Editor, Justin Mancini
The AAP released its 2026 childhood immunization schedule, maintaining evidence-based vaccine recommendations and expanding guidance across routine, catch-up, and risk-based care.
Advertisement
Advertisement
The American Academy of Pediatrics (AAP) has published the Recommended Childhood and Adolescent Immunization Schedule: United States 2026, reaffirming routine immunization to protect infants, children, and adolescents against 18 vaccine-preventable diseases. The schedule continues long-standing AAP guidance for vaccines targeting conditions such as respiratory syncytial virus (RSV), hepatitis A, hepatitis B, rotavirus, influenza, meningococcal disease, measles, and pertussis.1,2
Related to this article

A Contemporary Pediatrics Peer Exchange panel reviews RSV risk, testing, maternal vaccination, and long-acting monoclonal antibodies, and where infants still slip through the cracks.

Completing the DTaP primary series was 96.2% effective against pertussis in Alaska children aged 6 months to 6 years during a record 2024 outbreak.

Johanna Chang, MD, offers guidance on vaccination, infection prophylaxis, and clinical warning signs in children receiving biologic therapies.

A GBD analysis of 204 countries estimated measles cases in children under 5 rose from 11.1 million in 2019 to 15.6 million in 2023.

Missed the AAP's new congenital measles guidance? This easy-to-read FAQ covers what pediatric clinicians need to know.

Black race was the strongest predictor of T2-high inflammation in 451 children with severe asthma adjusted for social and environmental factors.
Advertisement
Advertisement


